Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more

Welcome back to another edition of Endpoints Weekly. We’re barreling toward the holiday season, which means it’s time for an early programming note: Our newsletters will go dark between Dec. 24 and Jan. 1. But ...